Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has issued an announcement.
Imricor Medical Systems has notified the market of the issue of 155,000 unquoted options under its employee incentive scheme, with various exercise prices and expiry dates, effective 1 January 2026. The new options, which will not be quoted on the ASX, form part of the company’s broader strategy to align staff incentives with shareholder interests and support retention and motivation of key employees as it advances its medical technology portfolio.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.22 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. is a medical device company focused on developing and commercialising cardiac electrophysiology products, particularly for use in MRI-guided cardiac ablation procedures. The company targets the global cardiovascular market, supplying specialised equipment and technologies designed to improve the safety and effectiveness of minimally invasive heart rhythm treatments.
Average Trading Volume: 192,377
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$506.3M
For a thorough assessment of IMR stock, go to TipRanks’ Stock Analysis page.